Isabelle Durand‐Zaleski

Inserm, Université Paris-Est Créteil, Hôtel-Dieu de Paris

Papers

4

Total Citations

18

H-Index

3

About

Isabelle Durand‐Zaleski is a leading health economist whose research focuses on the medico-economic evaluation of surgical innovations, particularly in gynecology and thoracic oncology. Her major contributions lie in rigorously assessing the cost-effectiveness of robotic-assisted surgery compared to traditional approaches, providing crucial evidence for healthcare decision-makers. Her most-cited work, a 2024 study on robot-assisted total hysterectomy for benign pathologies (7 citations), demonstrates that robotic surgery can be cost-effective relative to laparoscopy when considering societal perspectives. She has also evaluated robotic-assisted thoracic surgery in public hospitals (5 citations) and robotic myomectomy versus open surgery (3 citations), consistently highlighting the importance of procedure volume and operative time in determining economic viability. Earlier in her career, she contributed to the French evaluation of primary treatments for non-metastatic prostate cancer (3 citations). Her work is instrumental in guiding hospital adoption policies and reimbursement strategies for advanced surgical technologies, making her a key voice in the intersection of clinical outcomes and healthcare economics.

Research Focus

Key Achievements

3
H-Index
4
Papers
18
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Cost-effectiveness of robot-assisted total hysterectomy for benign pathologies compared to laparoscopic surgery: A retrospective study with propensity score
7 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Inserm, Université Paris-Est Créteil, Hôtel-Dieu de Paris

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago